Kymera is developing protein degrader therapies targeting IRAK4 for immune-inflammatory diseases.
#Biotechnology
Aetion delivers real-world evidence for life sciences, payers, providers, and regulatory agencies.
#Healthcare Technology
Science 37 develops decentralized clinical trials using digital technologies to streamline participant recruitment and retention.
#Clinical Research
GlycoMimetics focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs.
#Biotechnology
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding.
#Biotechnology
Granite Bio targets fundamentals of inflammation, autoimmunity, and fibrosis.
#Biotechnology
Icosavax focuses on developing safe and effective vaccines against infectious diseases.
#Biotechnology
Imbria Pharmaceuticals translates understanding of cellular metabolism into innovative medicines.
#Biotechnology
Immune Design activates the immune system's natural ability to create tumor-specific cytotoxic T cells to fight cancer and other chronic diseases.
#Biotechnology
Inozyme Pharma develops new medicines to treat rare disorders of calcification.
#Biotechnology
KaloBios focuses on the development of monoclonal antibody therapeutics.
#Biotechnology
LAVA Therapeutics develops a proprietary bispecific antibody platform that engages gamma-delta T cells.
#Biotechnology
Lumena Pharmaceuticals is dedicated to providing better treatment options for rare and debilitating liver diseases and serious metabolic disorders.
#Biotechnology
Lysosomal Therapeutics is dedicated to innovative small molecule research and development in the field of neurodegeneration.
#Biotechnology
MacroGenics focuses on discovering and developing innovative monoclonal antibody-based therapeutics.
#Biotechnology
Matchpoint is harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses.
#Biotechnology
Medisafe delivers a next-generation patient engagement and medication adherence solution.
#Digital Health
Minervax is developing a prophylactic vaccine against Group B Streptococcus.
#Biotechnology
Mirador is a next-generation precision medicine company focused on immunology and inflammation.
#Biotechnology
Muna Therapeutics discovers and develops therapies that slow or stop devastating neurodegenerative diseases.
#Biotechnology
Navitor is pioneering the selective targeting of mTORC1 activation to develop a new class of medicines for age-related diseases.
#Biotechnology
NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway.
#Biotechnology
NodThera is developing a new class of potent and selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation.
#Biotechnology
Normunity is identifying and targeting novel mechanisms to remove cancer's barriers to normal immunity.
#Biotechnology
Nucleai is leading the spatial biology revolution in precision medicine.
#Biotechnology
Nura Bio is developing neuroprotective therapies for the treatment of a broad range of neurological diseases.
#Biotechnology
Nuvig Therapeutics is developing a first-in-class Fc fragment immunomodulator aimed at improving autoimmune dysregulation without suppressing the immune system.
#Biotechnology
Odyssey is advancing a pipeline of potential first and best in class immunology and oncology programs.
#Biotechnology
Omada Health is a digital behavioral medicine company that inspires and enables people to change the habits that put them most at risk for chronic conditions.
#Digital Health
OMass Therapeutics is identifying new medicines using novel biochemistry techniques, native mass spectrometry and custom chemistry.
#Biotechnology
Ovid Therapeutics is committed to transforming the lives of patients with rare and orphan diseases of the brain.
#Biotechnology
Proteostasis Therapeutics is developing disease-modifying therapeutics for diseases of protein processing.
#Biotechnology
Q32 Bio is developing biologics to restore healthy immune regulation.
#Biotechnology
QurAlis is a clinical-stage biotechnology company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
#Biotechnology
ReCode Therapeutics is developing disease-modifying therapeutics using its powerful LNP delivery technology to target organs and tissues beyond the liver.
#Biotechnology
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
#Biotechnology
Selecta is developing immune modulating nanomedicines that enable novel biologic therapies by preventing harmful immune responses.
#Biotechnology
Sudo Biosciences is advancing best-in-class TYK2 targeted drugs.
#Biotechnology
T-Therapeutics is developing next generation TCR therapeutics to transform cancer treatment.
#Biotechnology
Therini Bio is focusing on developing novel therapies based on a deep understanding of fibrin.
#Biotechnology
Ultragenyx is committed to bringing to market life-transforming therapeutics for patients with rare and ultra-rare metabolic genetic diseases.
#Biotechnology
Unum Therapeutics uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body's own immune system to fight cancer.
#Biotechnology
Veralox Therapeutics Inc is developing first-in-class therapeutics targeting 12-Lipoxygenase (12-LOX) to bring new treatments to patients with rare blood disorders and diabetes.
#Biotechnology
Voluntis creates digital therapeutics that empower people suffering from chronic conditions to self-manage their treatment.
#Digital Health
Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding.
#Biotechnology
